and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir, a long-acting insulin, "failed to take into consideration patient access to affordable, long-acting insulin ...

The following November, however, the company said it would discontinue Levemir insulin by the end of 2024, and to expect supply disruptions from the middle of January, according to APIC.

This leaflet answers some common questions about Levemir ® FlexPen ®. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.